TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Laurantis Pharma Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
2
|
1 | |
| Financial expenses |
38
|
4,014
|
98 |
| Earnings before taxes |
-619
|
-6,463
|
-1,670 |
| Total assets |
285
|
84
|
5,826 |
| Current assets |
268
|
67
|
75 |
| Current liabilities |
171
|
192
|
162 |
| Equity capital |
-3,705
|
-3,087
|
3,376 |
| - share capital |
3
|
3
|
3 |
| Employees (average) | 1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
-1300%
|
-3675.0%
|
57.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-323150.0%
|
-167000% | |
| Return on assets (ROA) |
-203.9%
|
-2915.5%
|
-27.0% |
| Current ratio |
156.7%
|
34.9%
|
46.3% |
| Return on equity (ROE) |
16.7%
|
209.4%
|
-49.5% |
| Change turnover |
1
|
1 | |
| Change turnover % | 100% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.